+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey



Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey



Europace 15(1): 141-143



The purpose of this EP wire survey was to assess clinical practice in relation to the use of left atrial appendage occlusion (LAAO) devices for stroke prevention in atrial fibrillation (AF) among members of the European Heart Rhythm Association research network. The average number of performed LAAO was 10.6 per year and most (73%) centres performed ≤10 procedures per year. We found that LAAO was being performed for stroke prevention in AF, for the most common indication being 'the patient has absolute contraindication to long term oral anticoagulants'. Among survey respondents, LAAO procedures are most often performed by interventional cardiologists. Experience varied widely, and this was reflected in the wide range of thromboembolic and procedural (tamponade, bleeding) complications reported by the respondents to this EP wire survey.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036667642

Download citation: RISBibTeXText

PMID: 23233491

DOI: 10.1093/europace/eus413


Related references

Stroke prevention strategies in patients with atrial fibrillation and heart valve abnormalities: perceptions of 'valvular' atrial fibrillation: results of the European Heart Rhythm Association Survey. Europace 18(10): 1593-1598, 2016

Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey. Europace 15(10): 1526-1532, 2013

PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study. Eurointervention 6(2): 220-226, 2010

Left atrial appendage occluder implantation in Europe: indications and anticoagulation post-implantation. Results of the European Heart Rhythm Association Survey. Europace 19(10): 1737-1742, 2017

Left Atrial Appendage Occlusion for Secondary Stroke Prevention in Patients with Atrial Fibrillation: Long-Term Results. Cerebrovascular Diseases 47(3-4): 188-195, 2019

Transcatheter left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: results from the Belgian registry. Eurointervention 13(13): 1603-1611, 2018

Left atrial appendage occlusion for stroke prevention in diabetes mellitus patients with atrial fibrillation: Long-term results. Journal of Diabetes 11(1): 75-82, 2019

Left atrial appendage closure-indications, techniques, and outcomes: results of the European Heart Rhythm Association Survey. Europace 17(4): 642-646, 2015

Current practice of antiarrhythmic drug therapy for prevention of atrial fibrillation in Europe: The European Heart Rhythm Association survey. Europace 15(4): 478-481, 2013

Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation. Expert Review of Cardiovascular Therapy 13(8): 907-914, 2015

Left Atrial Appendage Occlusion for Stroke Prevention in Patients with Atrial Fibrillation. Interventional Cardiology Clinics 7(2): Xiii-Xxiv, 2018

Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation. Clinical Cardiology 40(10): 825-831, 2017

To occlude or not? Left atrial appendage occlusion for stroke prevention in atrial fibrillation. Heart 103(2): 93-95, 2017

Is left atrial appendage occlusion useful for prevention of stroke or embolism in atrial fibrillation?. Zeitschrift fuer Kardiologie 91(5): 376-379, Mai, 2002

Left atrial appendage occlusion with the WATCHMAN™ for stroke prevention in atrial fibrillation. Reviews in Cardiovascular Medicine 15(2): 142-151, 2014